Submitted by Anonymous (not verified) on 28 January 2026 - 14:30
Human medicines European public assessment report (EPAR): Oyavas, bevacizumab, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Oyavas, bevacizumab, Date of authorisation: 26/03/2021, Revision: 9, Status: Authorised